Association Between a Multi-Gene Panel and Renal Denervation Effectiveness in Patients With Hypertension

Trial ID or NCT#

NCT04060641

Status

not recruiting iconNOT RECRUITING

Purpose

The purpose of this study is to assess the effectiveness of a multi-gene panel to determine which subjects are likely to respond to renal denervation therapy with Medtronic's Symplicity Spyral™ multi-electrode renal denervation system.

Official Title

Association Between a Multi-Gene Panel and Renal Denervation Effectiveness in Patients With Hypertension

Eligibility Criteria

Ages Eligible for Study: 18 to 80
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. 1. Individual is currently or has previously been enrolled in a Medtronic clinical study utilizing the Symplicity Spyral™ multi-electrode renal denervation system.2. Subject received Renal Denervation.3. Subject has met the primary efficacy endpoint for the Medtronic Symplicity Spyral study and which arm they were randomized to.4. Individual agrees to have all study procedures performed, and is competent and willing to provide written, informed consent to participate in this clinical study.
    1. Exclusion Criteria:
      1. * Unable to provide written, informed, consent
Exclusion Criteria:
  1. * Unable to provide written, informed, consent
View All Criteria
Show Less

View on ClinicalTrials.gov